Penumbra, Inc. Aktie News

ALAMEDA, Calif. , May 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024.

Lightning Flash™ 2.0 features advanced computer assisted vacuum thrombectomy (CAVT) software, designed for increased efficiency and sensitivity to enhance removal of venous thrombus and treatment of pulmonary emboli (PE) Combined with streamlined audio-visual feedback, Lightning Flash 2.0 is designed to enable physicians to restore blood flow more quickly and further minimize blood loss ALAMEDA...

ALAMEDA, Calif. , April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern Time.

Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript

ALAMEDA, Calif. , Feb. 22, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2023.

ALAMEDA, Calif. , Feb. 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2023 after market close on Thursday, February 22, 2024 at 4:30 PM Eastern Time.

ALAMEDA, Calif. , Dec. 18, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P.

First-of-its-kind randomized controlled trial comparing computer assisted vacuum thrombectomy (CAVT) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone Penumbra's Indigo® Aspiration with Lightning portfolio offers the only CAVT technologies currently available in the U.S. and Lightning Flash is the latest advancement designed to allow physicians to remove large ...